B

Bristol Myers Squibb

Makes drugs for cancer, blood and immune diseases

Associate Director, Patient Safety Scientist

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeIn-person

About the Job

Requirements

  • A scientific degree (for example, BS, MS, PharmD, PhD, or MD), or another degree combined with equivalent relevant education and professional experience.
  • At least 6–8 years of relevant pharmacovigilance, pharmaceutical industry, or drug development experience, with the ability to mentor others.
  • Ability to co-develop and execute safety strategies across programs by synthesizing clinical, nonclinical, postmarketing, and literature data to inform decisions and influence stakeholders, using a deep understanding of medical concepts and safety activities.
  • Ability to manage team priorities, timelines, and quality; communicate and collaborate effectively; organize work; escalate risks to timelines or deliverables; work independently and as part of a team; and resolve program-level challenges in dynamic environments.
  • Ability to integrate scientific knowledge, analytical thinking, experience, and judgment to make sound decisions; apply attention to detail, conceptual thinking, and scientific training to interpret complex medical data across disciplines and develop strategic insights.
  • Understanding of data analysis, interpretation, and presentation, including foundational statistical methods, and ability to integrate emerging technologies such as artificial intelligence, automation, and digital platforms to optimize workflows, enhance data analysis, and maintain scientific rigor and compliance.

Responsibilities

  • Drive core signal detection and assessment activities throughout the product life cycle in partnership with the Safety Management Team Chair, including reviewing safety-related literature and performing quantitative signal detection; use a wide range of tools and data sources to assess safety concerns and support informed decision-making and proactive risk management.
  • Lead safety data review meetings by reviewing and evaluating clinical data to support signal detection; escalate issues affecting Safety Management Team activities, milestones, and documents to the Chair.
  • Drive the strategy and execution of signal evaluation, including case series, literature review, and health authority or claims databases; promote cross-functional collaboration; author signal reports with preliminary conclusions; and ensure timely tracking, stakeholder engagement, and documentation in the signal management system.
  • Execute strategy and provide medical writing for safety and risk management sections of aggregate safety documents, including DSUR, PBRER, and PADER.
  • Execute strategy, analyze data, and write ad hoc responses to health authorities, including supporting local markets with risk management-related queries; mentor less experienced scientists in this area.
  • Lead preparation, review, and strategic input for safety sections in clinical trial documents, including protocols, clinical study reports, investigator brochures and reference safety information, informed consent forms, and contraception language.
  • Represent Patient Safety and support safety strategy preparation at internal and external meetings, including pre-submission meetings, advisory committees, scientific advice meetings, data monitoring committee meetings, and publication meetings.
  • Execute safety strategy for regulatory filings, including contributing to safety strategy, key safety messages, and risk management approaches; review and author safety sections of marketing authorization applications, including safety table shells, Integrated Summary of Safety, Summary of Clinical Safety, clinical overviews, briefing books, and initial product labeling; author responses to ad hoc regulatory safety requests, such as 120-day safety updates; and source and interpret safety data to evaluate emerging safety issues and product benefit-risk profiles.
  • Provide input into strategy, analyze data, and author documentation to support safety labeling updates that reflect the emerging postmarketing safety profile.
  • Support the EU Qualified Person Responsible for Pharmacovigilance or other regional/local qualified persons on safety issues for assigned products.
  • Create and update the Emerging Drug Safety Report to characterize emerging safety concerns during asset development, support structured benefit-risk assessment, and define the company core risk management strategy; align with the Safety Management Team and governance, collaborating with Epidemiology on risk minimization effectiveness and non-interventional research activities for post-authorization safety studies.
  • Lead and oversee development and maintenance of global and EU Risk Management Plans, including understanding in-licensing arrangements and pharmacovigilance agreements that may affect risk management activities.
  • Lead and oversee creation and revision of global and local core additional Risk Minimization Measures and additional Pharmacovigilance Activities; guide local markets and vendors on complex measures such as Pregnancy Prevention Programs and Controlled Distribution Programs, and non-complex measures such as educational materials.
  • Use automation and innovation tools in daily work, understand current processes, and evaluate and suggest digital improvements; use multiple data sources and artificial intelligence-generated outputs to support decisions.
  • Engage regularly with therapeutic area staff, serve as a role model in cross-functional interactions, and contribute to a culture of excellence, accountability, and continuous improvement.
  • Support regulatory inspections and audits by evaluating current processes and assessing alignment with regulatory expectations, guidelines, and mandates.

About the Company

Bristol Myers Squibb

Makes drugs for cancer, blood and immune diseases

Bristol Myers Squibb discovers, develops and sells prescription medicines for serious illnesses, including cancer, blood disorders, immune diseases and heart disease, for patients treated by doctors and hospitals around the world. Its best-known drug is Opdivo, an immunotherapy that helps the body's own immune system find and attack many kinds of cancer. Researchers develop drug candidates in its labs or bring them in through acquisitions and partnerships, then test them in clinical trials to win regulatory approval. The company makes and markets the approved medicines and earns its revenue from sales of patent-protected drugs. Its roots go back to a business founded in 1887, and it is based in Lawrence Township, New Jersey.

Company size
10,001+
Company stage
IPO
Headquarters
Lawrence Township, NJ
Founded
1887

Recently Posted Jobs

Explore more opportunities at Bristol Myers Squibb

See more jobs